| 1 | FPLD3,PPARG
|
| Familial partial lipodystrophy phenotype resulting from a single-base mutation in deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma.
|
| Monajemi H, Zhang L, Li G, Jeninga EH, Cao H, Maas M, Brouwer CB, Kalkhoven E, Stroes E, Hegele RA, Leff T.
|
| J Clin Endocrinol Metab 92(5):1606-12. Epub 2007 Feb 13. 2007
|
| 2 | PPARG, FPLD3
|
| Peroxisomal proliferator activated receptor-gamma deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3).
|
| Francis GA, Li G, Casey R, Wang J, Cao H, Leff T, Hegele RA.
|
| BMC Med Genet 7:3. 2006
|
| 3 | FPLD3, PPARG
|
| A frameshift mutation in peroxisome-proliferator-activated receptor-gamma in familial partial lipodystrophy subtype 3 (FPLD3; MIM 604367).
|
| Hegele RA, Ur E, Ransom TP, Cao H.
|
| Clin Genet 70(4):360-2. No abstract available. 2006
|
| 4 | FPLD3, PPARG
|
| PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy.
|
| Hegele RA, Cao H, Frankowski C, Mathews ST, Leff T.
|
| Diabetes 51(12):3586-90. 2002
|
| 5 | PPARG, FPLD3
|
| A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy.
|
| Agarwal AK, Garg A.
|
| J Clin Endocrinol Metab 87(1):408-11. 2002
|